Inside Scanbo’s AI heart-screening push
In India, heart emergencies often go undetected due to the lack of 12-lead ECG machines in smaller clinics. Scanbo Technologies, based in Surat, aims to address this issue with its palm-sized device called D8. The device records a single-lead ECG and sends the tracing to an AI engine, HridayTaal, for interpretation. The AI algorithm checks for abnormalities such as abnormal heart rate, atrial fibrillation, or sinus arrhythmia.
It also considers the patient's age, gender, blood pressure, heart rate, blood oxygen level, and glucose levels. Raichura, the founder and CEO of Scanbo, emphasizes that the device is an aid for healthcare professionals, not a replacement for a cardiologist. The company has trained the AI model using real ECGs from various libraries and has achieved accuracy above 95%.
Scanbo has deployed over 1,000 devices globally, with 70-80% of them used daily, and 80-85% of active customers paying regularly. The responsibility of diagnosing the ECG remains with the doctor, as the company does not diagnose or take responsibility for the AI's findings.
Written by urgent.news from The Economic Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
